- Report
- October 2022
- 133 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- May 2022
- 37 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- May 2022
- 38 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- May 2022
- 54 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- May 2022
- 40 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- April 2021
- 105 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- March 2021
Global
From €2413EUR$2,500USD£2,070GBP
- Drug Pipelines
- November 2020
- 139 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- November 2019
- 58 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- July 2023
- 84 Pages
China
From €1737EUR$1,800USD£1,490GBP
- Report
- July 2023
- 104 Pages
China
From €1737EUR$1,800USD£1,490GBP
- Report
- February 2024
- 168 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- October 2020
- 219 Pages
Global
From €5568EUR$5,769USD£4,776GBP
- Report
- January 2020
- 228 Pages
Global
From €5183EUR$5,370USD£4,446GBP
- Report
- January 2020
- 202 Pages
Global
From €5183EUR$5,370USD£4,446GBP
- Report
- May 2023
- 160 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Report
- April 2023
- 160 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Report
- April 2023
- 160 Pages
Global
From €5790EUR$5,999USD£4,967GBP
The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease.
The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more